Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-16 9:52 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 9,705,857 9.100% | 28,000 (+0.29%) | View |
| 2024-11-15 6:03 pm Purchase | 13G | INDIVIOR PLC INDV | Flynn James E | 7,363,210 5.800% | 7,363,210 (New Position) | View |
| 2024-11-14 09:56 am Purchase | 13G | DocGo Inc. DCGO | Flynn James E | 9,066,138 8.880% | 3,745,999 (+70.41%) | View |
| 2024-11-14 09:55 am Sale | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Flynn James E | 6,229,634 5.220% | -2,659,267 (-29.92%) | View |
| 2024-11-14 09:03 am Sale | 13G | AdaptHealth Corp. AHCO | Flynn James E | 23,758,393 7.220% | -3,896,530 (-14.09%) | View |
| 2024-11-14 09:02 am Sale | 13G | Verastem Inc. VSTM | Flynn James E | 0 0.000% | -1,538,461 (Position Closed) | View |
| 2024-11-14 09:01 am Sale | 13G | NUO THERAPEUTICS INC AURX | Flynn James E | 1,026,324 2.200% | -1,156,840 (-52.99%) | View |
| 2024-11-14 09:00 am Sale | 13G | HILLEVAX INC HLVX | Flynn James E | 1,882,654 3.780% | -2,121,577 (-52.98%) | View |
| 2024-11-14 08:59 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | Flynn James E | 1,781,006 1.900% | -2,697,586 (-60.23%) | View |
| 2024-11-14 08:57 am Purchase | 13G | Ventyx Biosciences Inc. VTYX | Flynn James E | 6,715,501 9.500% | 3,173,501 (+89.60%) | View |
| 2024-11-14 08:56 am Sale | 13G | Solid Biosciences Inc. SLDB | Flynn James E | 0 0.000% | -2,260,398 (Position Closed) | View |
| 2024-11-14 08:55 am Sale | 13G | NKARTA INC NKTX | Flynn James E | 2,155,000 3.050% | -1,245,000 (-36.62%) | View |
| 2024-11-14 08:54 am Purchase | 13G | MERUS N V COM MRUS | Flynn James E | 3,408,539 4.980% | 388,638 (+12.87%) | View |
| 2024-11-14 08:54 am Purchase | 13G | Mallinckrodt plc MNKTQ | Flynn James E | 1,460,233 7.410% | 179,000 (+13.97%) | View |
| 2024-11-14 08:53 am Unchanged | 13G | WINDTREE THERAPEUTICS INC WINT | Flynn James E | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-12 6:58 pm Purchase | 13G | Oscar Health Inc. OSCR | Flynn James E | 11,835,000 5.590% | 588,180 (+5.23%) | View |
| 2024-11-08 4:49 pm Purchase | 13G | Lomond Therapeutics Holdings Inc. | Flynn James E | 2,692,625 9.900% | 2,692,625 (New Position) | View |
| 2024-11-01 7:54 pm Unchanged | 13D | Singular Genomics Systems Inc. OMIC | Flynn James E | 249,495 6.660% | 0 (Unchanged) | View |
| 2024-10-25 5:45 pm Purchase | 13G | Embecta Corp. EMBC | Flynn James E | 3,075,335 5.330% | 3,075,335 (New Position) | View |
| 2024-09-20 6:00 pm Purchase | 13G | FOGHORN THERAPEUTICS INC FHTX | Flynn James E | 2,935,295 5.310% | 2,935,295 (New Position) | View |